European Federation of Psychiatric Trainees

Last updated
European Federation of Psychiatric Trainees
Formation1993
Headquarters20, Avenue de la Couronne 1050 Bruxelles (Ixelles), Belgium
Membership
38 European countries
President
Mette Konings, M.D.
Website efpt.eu

The European Federation of Psychiatric Trainees (EFPT) is a non-profit organization for European national psychiatric trainees. [1] [2] It is a federation of the national trainees associations (NTA) of psychiatric trainees of about 38 European nations.

Contents

Organization

The EFPT is a non-profit organization registered under Belgian law. The governing body of the EFPT is the General Assembly, which meets annually. [3] A board of directors (Board members) is annualy elected by the General Assembly. Board members work as a team to fulfil the EFPTs goals and projects, with the help of General Managers, who are elected by Board members. [4]

Statements

The EFPT produces statements that form the basis of the EFPT's work and are communicated to partner organizations. [3] [5] [6]

Projects and Working Groups

The EFPT has a community of active working groups organizing events dedicated to the improvement of trainees' knowledge and skills (e.g., psychopathology, research methods, leadership, neuropsychopharmacology). [7]

Research

In the past, the EFPT led several research projects about :

The EFPT also conceived materials promoting a positive image of psychiatry, with some videos targeting stigmatization. [12]

Related Research Articles

Psychosis is a condition of the mind or psyche that results in difficulties determining what is real and what is not real. Symptoms may include delusions and hallucinations, among other features. Additional symptoms are disorganized thinking and incoherent speech and behavior that is inappropriate for a given situation. There may also be sleep problems, social withdrawal, lack of motivation, and difficulties carrying out daily activities. Psychosis can have serious adverse outcomes.

<span class="mw-page-title-main">Schizoid personality disorder</span> Personality disorder involving extreme asociality

Schizoid personality disorder is a personality disorder characterized by a lack of interest in social relationships, a tendency toward a solitary or sheltered lifestyle, secretiveness, emotional coldness, detachment, and apathy. Affected individuals may be unable to form intimate attachments to others and simultaneously possess a rich and elaborate but exclusively internal fantasy world. Other associated features include stilted speech, a lack of deriving enjoyment from most activities, feeling as though one is an "observer" rather than a participant in life, an inability to tolerate emotional expectations of others, apparent indifference when praised or criticized, all forms of asexuality, and idiosyncratic moral or political beliefs.

<span class="mw-page-title-main">Necrophobia</span> Fear of dead organisms

Necrophobia is a specific phobia, the irrational fear of dead organisms as well as things associated with death. With all types of emotions, obsession with death becomes evident in both fascination and objectification. In a cultural sense, necrophobia may also be used to mean a fear of the dead by a cultural group, e.g., a belief that the spirits of the dead will return to haunt the living.

<span class="mw-page-title-main">David Healy (psychiatrist)</span> Irish-born pharmacologist

David HealyFRCPsych, a professor of psychiatry at Bangor University in the United Kingdom, is a psychiatrist, psychopharmacologist, scientist and author. His main areas of research are the contribution of antidepressants to suicide, conflict of interest between pharmaceutical companies and academic medicine, and the history of pharmacology. Healy has written more than 150 peer-reviewed articles, 200 other articles, and 20 books, including The Antidepressant Era, The Creation of Psychopharmacology, The Psychopharmacologists Volumes 1–3, Let Them Eat Prozac and Mania: A Short History of Bipolar Disorder.

<span class="mw-page-title-main">Hyperfocus</span> Intense form of mental concentration

Hyperfocus is an intense form of mental concentration or visualization that focuses consciousness on a subject, topic, or task. In some individuals, various subjects or topics may also include daydreams, concepts, fiction, the imagination, and other objects of the mind. Hyperfocus on a certain subject can cause side-tracking away from assigned or important tasks.

In medicine and medical anthropology, a culture-bound syndrome, culture-specific syndrome, or folk illness is a combination of psychiatric and somatic symptoms that are considered to be a recognizable disease only within a specific society or culture. There are no known objective biochemical or structural alterations of body organs or functions, and the disease is not recognized in other cultures. The term culture-bound syndrome was included in the fourth version of the Diagnostic and Statistical Manual of Mental Disorders which also includes a list of the most common culture-bound conditions. Its counterpart in the framework of ICD-10 is the culture-specific disorders defined in Annex 2 of the Diagnostic criteria for research.

<span class="mw-page-title-main">Kynurenine</span> Chemical compound

l-Kynurenine is a metabolite of the amino acid l-tryptophan used in the production of niacin.

Dark therapy is the practice of keeping people in complete darkness for extended periods of time in an attempt to treat psychological conditions. The human body produces the melatonin hormone, which is responsible for supporting the circadian rhythms. Darkness seems to help keep these circadian rhythms stable.

<span class="mw-page-title-main">Tiapride</span> Antipsychotic medication

Tiapride is a drug that selectively blocks D2 and D3 dopamine receptors in the brain. It is used to treat a variety of neurological and psychiatric disorders including dyskinesia, alcohol withdrawal syndrome, negative symptoms of psychosis, and agitation and aggression in the elderly. A derivative of benzamide, tiapride is chemically and functionally similar to other benzamide antipsychotics such as sulpiride and amisulpride known for their dopamine antagonist effects.

<span class="mw-page-title-main">Occupational burnout</span> Type of occupational stress

The ICD-11 of the World Health Organization (WHO) describes occupational burnout as an occupational phenomenon resulting from chronic workplace stress that has not been successfully managed, with symptoms characterized by "feelings of energy depletion or exhaustion; increased mental distance from one’s job, or feelings of negativism or cynicism related to one's job; and reduced professional efficacy." It is classified as an occupational phenomenon, but is not recognized by the WHO as a medical condition.

Carl Schneider, professor at Heidelberg University, (1933–1945) chairman of its department of Psychiatry, director of its clinic, was a senior researcher for the Action T4 euthanasia program.

<span class="mw-page-title-main">Panic disorder</span> Anxiety disorder characterized by reoccurring unexpected panic attacks

Panic disorder is a mental and behavioral disorder, specifically an anxiety disorder characterized by reoccurring unexpected panic attacks. Panic attacks are sudden periods of intense fear that may include palpitations, sweating, shaking, shortness of breath, numbness, or a feeling that something terrible is going to happen. The maximum degree of symptoms occurs within minutes. There may be ongoing worries about having further attacks and avoidance of places where attacks have occurred in the past.

Sophia Frangou is a professor of psychiatry at the Icahn School of Medicine at Mount Sinai where she heads the Psychosis Research Program. She is a Fellow of the Royal College of Psychiatrists and vice-chair of the RCPsych Panamerican Division. She is a Fellow of the European Psychiatric Association (EPA) and of the American Psychiatric Association (APA). She served as vice-president for Research of the International Society for Bipolar Disorders from 2010 to 2014. She has also served on the Council of the British Association for Psychopharmacology. She is founding member of the EPA NeuroImaging section and founding chair of the Brain Imaging Network of the European College of Neuropsychopharmacology. She is one of the two Editors of European Psychiatry, the official Journal of the European Psychiatric Association.

Anxiety/aggression-driven depression is a prospective subtype of major depressive disorder first proposed by the Dutch psychiatrist Herman M. van Praag in 1996. Van Praag has continued to write on this topic in subsequent academic articles.

<span class="mw-page-title-main">Andreas Heinz (psychotherapist)</span> German psychiatrist and neurologist

Andreas Heinz is a German psychiatrist and neurologist.

Psychological autopsy in suicidology is a systematic procedure for evaluating suicidal intention in equivocal cases. It was invented by American psychologists Norman Farberow and Edwin S. Shneidman during their time working at the Los Angeles Suicide Prevention Center, which they founded in 1958.

Metacognitive training (MCT) is an approach for treating the symptoms of psychosis in schizophrenia, especially delusions, which has been adapted for other disorders such as depression, obsessive–compulsive disorder and borderline over the years. It was developed by Steffen Moritz and Todd Woodward. The intervention is based on the theoretical principles of cognitive behavioral therapy, but focuses in particular on problematic thinking styles that are associated with the development and maintenance of positive symptoms, e.g. overconfidence in errors and jumping to conclusions. Metacognitive training exists as a group training (MCT) and as an individualized intervention (MCT+).

Danuta Elizabeth Wasserman is a professor of psychiatry and suicidology at Karolinska Institutet in Sweden. She is a public mental health and medical educator. She is currently the President of the World Psychiatric Association (WPA).

<span class="mw-page-title-main">David Taylor (professor)</span>

David Taylor FFRPS FRPharmS is a British professor. He is the head of the Pharmaceutical Sciences Clinical Academic Group within King's Health Partners. Taylor has been lead author and editor of the Maudsley Prescribing Guidelines in Psychiatry since 1994. In 2014, Taylor was named as one of the top 100 clinical leaders in the UK National Health Service.

Narcissistic perversion is a psychoanalytical term resulting from the association of two Freudian notions: perversion and narcissism. It is characterised by an organised way of defending oneself from all the internal pain or contraindications and expelling them elsewhere, while at the same time overrating oneself with enjoyment.

References

  1. Nawka A; et al. (Sep 2010). "Mental health reforms in Europe: challenges of postgraduate psychiatric training in Europe: a trainee perspective". Psychiatric Services. 61 (9): 862–4. doi:10.1176/ps.2010.61.9.862. PMID   20810581.
  2. Schulze TG, Treichel KC (Sep 2002). "The European Federation of Psychiatric Trainees (EFPT)--an integral part of the European harmonisation of psychiatric education and practise". European Psychiatry. 17 (5): 300–5. doi:10.1016/s0924-9338(02)00671-5. PMID   12510630. S2CID   32940962.
  3. 1 2 Nawka, A.; Rojnic Kuzman, M.; Giacco, D.; Wuyts, P.; Simmons, M.; Favre, G.; Bausch Becker, N. (2011). "ECP09-01 - European federation of psychiatric trainees: Visions for the future". European Psychiatry. 26: 1805. doi:10.1016/S0924-9338(11)73509-X. S2CID   145699528.
  4. "Statements". European Federation of Psychiatric Trainees. 2014-07-19. Retrieved 2019-12-26.
  5. European Union of Medical Specialists. Section and Board of Psychiatry. Approved 17 October 2009. European framework for competencies in psychiatry.
  6. F. Riese, S. Guloksuz (2014). "Pharmaceutical industry interactions of psychiatric trainees from 20 European countries". European Psychiatry. 30 (2): 284–290. doi:10.1016/j.eurpsy.2014.09.417. PMID   25456156. S2CID   22392160.
  7. Jovanović, N.; Podlesek, A.; Volpe, U.; Barrett, E.; Ferrari, S.; Rojnic Kuzman, M.; Wuyts, P.; Papp, S.; Nawka, A.; Vaida, A.; Moscoso, A.; Andlauer, O.; Tateno, M.; Lydall, G.; Wong, V.; Rujevic, J.; Platz Clausen, N.; Psaras, R.; Delic, A.; Losevich, M. A.; Flegar, S.; Crépin, P.; Shmunk, E.; Kuvshinov, I.; Loibl-Weiß, E.; Beezhold, J. (2016-02-01). "Burnout syndrome among psychiatric trainees in 22 countries: Risk increased by long working hours, lack of supervision, and psychiatry not being first career choice" (PDF). European Psychiatry. 32 (Supplement C): 34–41. doi:10.1016/j.eurpsy.2015.10.007. ISSN   0924-9338. PMID   26802982. S2CID   28266739.
  8. Costa, M. Pinto da; Giurgiuca, A.; Holmes, K.; Biskup, E.; Mogren, T.; Tomori, S.; Kilic, O.; Banjac, V.; Molina-Ruiz, R.; Palumbo, C.; Frydecka, D.; Kaaja, J.; El-Higaya, E.; Kanellopoulos, A.; Amit, B. H.; Madissoon, D.; Andreou, E.; Uleviciute-Belena, I.; Rakos, I.; Dragasek, J.; Feffer, K.; Farrugia, M.; Mitkovic-Voncina, M.; Gargot, T.; Baessler, F.; Pantovic-Stefanovic, M.; Picker, L. De (2017-09-01). "To which countries do European psychiatric trainees want to move to and why?". European Psychiatry. 45: 174–181. doi:10.1016/j.eurpsy.2017.06.010. ISSN   0924-9338. PMID   28957784. S2CID   4920188 . Retrieved 2017-12-29.
  9. Gargot, T.; Dondé, C.; Arnaoutoglou, N. A.; Klotins, R.; Marinova, P.; Silva, R.; Sönmez, E. (2017-09-01). "How is psychotherapy training perceived by psychiatric trainees? A cross-sectional observational study in Europe". European Psychiatry. 45 (Supplement C): 136–138. doi:10.1016/j.eurpsy.2017.05.030. hdl: 11424/219194 . ISSN   0924-9338. PMID   28756112. S2CID   207678070.
  10. AFFEP EFPT Psychiatric cliche 1st Real doctor , retrieved 2019-12-26